Fig. 2
From: Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome
GDF15 levels across case and control populations. The plot illustrates the range of circulating GDF15 levels measured at baseline visits across the four study cohorts. No statistically significant difference in GDF15 was observed between the groups. Mean values are marked in each group. MS multiple sclerosis, ME/CFSmm myalgic encephalomyelitis/chronic fatigue syndrome with mild/moderate symptoms, ME/CFSsa myalgic encephalomyelitis/chronic fatigue syndrome severely affected by symptoms